Do hepatocellular carcinomas located in subcapsular space or in proximity to vessels increase the rate of local tumor progression? A meta-analysis
- PMID: 29924963
- DOI: 10.1016/j.lfs.2018.06.016
Do hepatocellular carcinomas located in subcapsular space or in proximity to vessels increase the rate of local tumor progression? A meta-analysis
Abstract
Aims: To determine if tumors located in the subcapsular space or in proximity to vessels would be a risk factor of local tumor progression (LTP2) in hepatocellular carcinomas (HCC) after radiofrequency ablation.
Materials and methods: A search of the MEDLINE, EMBASE and Cochrane Library databases from 1998 to 2017 was performed to identify studies examining the risk factors of LTP after radiofrequency ablation (RFA3) in HCC. No language or other restrictions were imposed. Summary estimates of risk factors of LTP were obtained by using a random-effects model with further exploration with meta-regression and sub-group analyses.
Key findings: There were 16 studies included, of which 7 were focused on the association of LTP with tumors abutting vessels, and 15 focused on tumors of subcapsular location. In total, 2870 patients were included. Tumors that were located in the subcapsular area had a higher occurrence of LTP (P = 0.04) with a high heterogeneity (I2 = 65%), which could not be explained by the results of the meta-regression. However, tumor that were in close to vessels had contrary results (P = 0.54) with a high heterogeneity (I2 = 77%).
Significance: The findings of the present meta-analysis indicate that the subscapsular location is a possible risk factor of LTP. Nevertheless, a clear definition or classification of the subcapsular location should be highlighted in future studies. Whether tumor location adjacent to a vessel has an influence on the incidence of LTP remains controversial, and more relevant research should be performed.
Keywords: Local tumor progression; Radiofrequency ablation; Subcapsular; Vessels.
Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Long-term Therapeutic Outcomes of Radiofrequency Ablation for Subcapsular versus Nonsubcapsular Hepatocellular Carcinoma: A Propensity Score Matched Study.Radiology. 2016 Jul;280(1):300-12. doi: 10.1148/radiol.2016151243. Epub 2016 Jan 29. Radiology. 2016. PMID: 26824711
-
Laparoscopic radiofrequency ablation of subcapsular hepatocellular carcinomas: risk factors related to a technical failure.Surg Endosc. 2022 Jan;36(1):504-514. doi: 10.1007/s00464-021-08310-7. Epub 2021 Feb 1. Surg Endosc. 2022. PMID: 33523278
-
[Transarterial chemoembolization plus computed tomography-guided percutaneous radiofrequency ablation for small hepatocellular carcinoma in special locations].Zhonghua Yi Xue Za Zhi. 2013 Sep 3;93(33):2627-30. Zhonghua Yi Xue Za Zhi. 2013. PMID: 24360041 Clinical Trial. Chinese.
-
Percutaneous radiofrequency ablation therapy of hepatocellular carcinoma using multitined expandable electrodes: comparison of subcapsular and nonsubcapsular tumors.AJR Am J Roentgenol. 2006 May;186(5 Suppl):S269-74. doi: 10.2214/AJR.04.1346. AJR Am J Roentgenol. 2006. PMID: 16632687
-
Radiofrequency ablation versus hepatic resection for small hepatocellular carcinoma: a meta-analysis of randomized controlled trials.J Clin Gastroenterol. 2014 May-Jun;48(5):450-7. doi: 10.1097/MCG.0000000000000008. J Clin Gastroenterol. 2014. PMID: 24172183 Review.
Cited by
-
Laparoscopic Hepatic Resection Versus Laparoscopic Radiofrequency Ablation for Subcapsular Hepatocellular Carcinomas Smaller Than 3 cm: Analysis of Treatment Outcomes Using Propensity Score Matching.Korean J Radiol. 2022 Jun;23(6):615-624. doi: 10.3348/kjr.2021.0786. Epub 2022 Mar 8. Korean J Radiol. 2022. PMID: 35289151 Free PMC article.
-
Radiofrequency ablation versus repeat hepatectomy in the treatment of recurrent hepatocellular carcinoma in subcapsular location: a retrospective cohort study.World J Surg Oncol. 2021 Jun 14;19(1):175. doi: 10.1186/s12957-021-02277-4. World J Surg Oncol. 2021. PMID: 34127007 Free PMC article.
-
Multiple-Electrode Switching-Based Radiofrequency Ablation vs. Conventional Radiofrequency Ablation for Single Early-Stage Hepatocellular Carcinoma Ranging From 2 to 5 Cm.Front Oncol. 2020 Jul 24;10:1150. doi: 10.3389/fonc.2020.01150. eCollection 2020. Front Oncol. 2020. PMID: 32793484 Free PMC article.
-
Laparoscopic radiofrequency ablation versus percutaneous radiofrequency ablation for subphrenic hepatocellular carcinoma.Ultrasonography. 2022 Jul;41(3):543-552. doi: 10.14366/usg.21241. Epub 2022 Feb 9. Ultrasonography. 2022. PMID: 35430787 Free PMC article.
-
New next-generation microwave thermosphere ablation for small hepatocellular carcinoma.Clin Mol Hepatol. 2021 Oct;27(4):564-574. doi: 10.3350/cmh.2021.0136. Epub 2021 Aug 2. Clin Mol Hepatol. 2021. PMID: 34333957 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical